AnodyneWiki

Naratriptan

Naratriptan
Naratriptan
Salts
[]
Naratriptan hydrochloride
Naratriptan hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass335.50 g/mol [1]
Melting point246 °C (HCl salt) [1]
Solubility35 mg/mL [1]
Predicted LogP2 [1]
Structural Identifiers
[]
Molecular formulaC17H25N3O2S
IUPAC nameN-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide
SMILESCNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
InChIInChI=1S/C17H25N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-4,11-12,14,18-19H,5-10H2,1-2H3
InChIKeyAMKVXSZCKVJAGH-UHFFFAOYSA-N
CAS number121679-13-8
UNIIQX3KXL1ZA2
PubChem CID4440
Pharmacokinetics[]
Elimination half-life5–8 hours
MetabolismHepatic
ExcretionRenal
Routes of administrationOral

Naratriptan (also known as Naramig, naratriptanum, 1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, N-methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide, N-Methyl-2-(3-(1-methylpiperidin-4-yl)-1H-indol-5-yl)ethanesulfonamide, N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide, N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethane-1-sulfonamide, N-methyl-2-(3-(1-methylpiperidin-4-yl)-1H-indol-5-yl)ethane-1-sulfonamide, N-methyl-2-(3-(1-methyl-4-piperidyl)-1H-indol-5-yl)-ethanesulfonamide or N02cc02).

Chemistry

Salts []

Naratriptan is typically found in the form of its hydrochloride salt.

 []

Naratriptan is achiral.

Naratriptan matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Three distinct pharmacological actions have been implicated in the antimigraine effect of the triptans: (1) stimulation of presynaptic 5-HT1D receptors, which serves to inhibit both dural vasodilation and inflammation; (2) direct inhibition of trigeminal nuclei cell excitability via 5-HT1B/1D receptor agonism in the brainstem and (3) vasoconstriction of meningeal, dural, cerebral or pial vessels as a result of vascular 5-HT1B receptor agonism. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

induction / metabolism / inhibition71 (4 contraindicated)
metabolism / inhibition / induction25 (1 contraindicated)
induction / metabolism / inhibition22 (1 contraindicated)
metabolism / inhibition10 (2 contraindicated)
metabolism / inhibition9 (1 contraindicated)
shared target7 (6 contraindicated)
shared target6 (6 contraindicated)
metabolism2 (1 contraindicated)

Medical side effects []

188 side effects listed on drug labels in (naratriptan).

  • Infection
  • Nausea
  • Vomiting
  • Migraine
  • Feeling hot
  • Paraesthesia
  • Sensation of pressure
  • Vertigo
  • Dry mouth
  • Photophobia
  • Dizziness
  • Syncope
  • Somnolence
  • Asthenia
  • Fatigue
  • Pain
  • Stinging
  • Malaise
  • Discomfort
  • Feeling abnormal
  • Feeling strange
  • Confusional state
  • Ill-defined disorder
  • Anxiety
  • Arthralgia
  • Musculoskeletal discomfort
  • Myalgia
  • Atrial fibrillation
  • Atrial flutter
  • Bronchitis
  • Cognitive disorder
  • Constipation
  • Cough
  • Cystitis
  • Bladder pain
  • Cystitis noninfective
  • Dehydration
  • Depression
  • Dysthymic disorder
  • Diarrhoea
  • Polyuria
  • Oedema
  • Body temperature increased
  • Gastroenteritis
  • Inflammation
  • Muscle spasms
  • Palpitations
  • Pneumonia
  • Urine output increased
  • Pruritus
  • Rheumatic disorder
  • Sinusitis
  • Hyperhidrosis
  • Swelling
  • Thirst
  • Tinnitus
  • Tremor
  • Urticaria
  • Tachyarrhythmia
  • Chills
  • Polydipsia
  • Ventricular extrasystoles
  • Fluid retention
  • Balance disorder
  • Vision blurred
  • Blood pressure increased
  • Electrocardiogram abnormal
  • Electrocardiogram PR prolongation
  • Phonophobia
  • Sleep disorder
  • Electrocardiogram QT prolonged
  • Abdominal discomfort
  • Muscle rigidity
  • Shock
  • Loss of consciousness
  • Musculoskeletal stiffness
  • Dissociation
  • Aggression
  • Alopecia
  • Anaphylactic shock
  • Anaphylactoid reaction
  • Anaemia
  • Aphasia
  • Asthma
  • Libido decreased
  • Disturbance in sexual arousal
  • Dermatitis
  • Rash
  • Oesophagitis
  • Eye haemorrhage
  • Muscle contractions involuntary
  • Folliculitis
  • Gastritis
  • Glycosuria
  • Hallucination
  • Cardiac murmur
  • Haemorrhage
  • Haemoglobin
  • Haemorrhoids
  • Hostility
  • Hypercholesterolaemia
  • Hyperaesthesia
  • Hyperglycaemia
  • Hyperlipidaemia
  • Hypersensitivity
  • Hypoaesthesia
  • Numbness
  • Hypotension
  • Hypothyroidism
  • Labyrinthitis
  • Mastitis
  • Neuralgia
  • Neuritis
  • Neuropathy peripheral
  • Panic reaction
  • Parathyroid tumour
  • Pleurisy
  • Purpura
  • Vascular purpura
  • Pyelonephritis
  • Scotoma
  • Convulsion
  • Sialoadenitis
  • Skin disorder
  • Gastric ulcer
  • Thrombocytopenia
  • Tracheitis
  • Ulcer
  • Erythema
  • Urinary incontinence
  • Vaginal inflammation
  • Vaginal infection
  • Pollakiuria
  • Micturition urgency
  • Agitation
  • Hyperkinesia
  • Breast discharge
  • Liver function test abnormal
  • Bone pain
  • Eye pain
  • Dry skin
  • Ketonuria
  • Muscle twitching
  • Haemorrhage urinary tract
  • Salivary gland enlargement
  • Dry eye
  • Photosensitivity reaction
  • Psychomotor retardation
  • Bradycardia
  • Coordination abnormal
  • Paralysis
  • Altered state of consciousness
  • Depressed level of consciousness
  • Mass
  • Dermatitis atopic
  • Oral pruritus
  • Blood bilirubin abnormal
  • Regurgitation
  • Rhinitis allergic
  • Angina pectoris
  • Arteriospasm coronary
  • Ischaemia
  • Myocardial infarction
  • Acute coronary syndrome
  • Colitis ischaemic
  • Prinzmetal angina
  • Arrhythmia
  • Cerebral infarction
  • Transient ischaemic attack
  • Dyspnoea
  • Gastrointestinal disorder
  • Headache
  • Cardiac disorder
  • Blood disorder
  • Immune system disorder
  • Nervous system disorder
  • Sensory loss
  • Cerebrovascular accident
  • Subarachnoid haemorrhage
  • Angiopathy
  • Ventricular fibrillation
  • Ventricular tachycardia
  • Vasospasm
  • Burning sensation
  • Myocardial ischaemia
  • Pain in jaw
  • Serotonin syndrome
  • Medication overuse headache

Indications

  • Aura
  • Cluster headache
  • Migraine

 []

  • Other: Naratriptan is a Rx-only.

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 4440, Naratriptan. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4440
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Naratriptan. UNII: QX3KXL1ZA2. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/QX3KXL1ZA2

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 11:53:58
drugspromissing (no DrugsPRO reagent data)2026-11-20 11:53:54
erowidmissing (no Erowid substance of that name)2026-11-20 11:53:54
gsrsok2026-11-20 11:53:56
hmdbmissing (hmdb.ca refused automated access to HMDB0015087)2026-11-20 11:53:54
keggok2026-11-20 11:53:56
pubchemok2026-11-20 11:53:54
redditmissing (no r/tripreports posts mention it)2026-11-20 11:53:54
siderok2026-11-20 11:53:55
structureok2026-11-20 11:53:54
wikipediaok2026-11-20 11:53:54